✦ LIBER ✦

Optimizing screening technology: how much to invest? – Reply

✍ Scribed by J.Fraser Glickman

Book ID: 114383461
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 64 KB
Volume: 6
Category: Article
ISSN: 1359-6446
DOI: 10.1016/s1359-6446(01)01711-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimizing screening technology: how muc

Optimizing screening technology: how much to invest?

✍ J.Fraser Glickman 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 37 KB

How much lift to the UPLIFT study? – Aut

How much lift to the UPLIFT study? – Authors' reply

✍ Marc Decramer; Steven Kesten; Bart Celli; Donald P Tashkin 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 72 KB

Are We Consuming Too Much?. It turns out

Are We Consuming Too Much?. It turns out we may be worrying too much about how much we consume and far too little about how to invest

✍ Christensen, Jon 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 22 KB

How much fat is necessary to optimize lu

How much fat is necessary to optimize lumefantrine oral bioavailability?

✍ Elizabeth A. Ashley; Kasia Stepniewska; Niklas Lindegårdh; Anna Annerberg; Am Kh 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 498 KB

How to evaluate emerging technologies in

How to evaluate emerging technologies in cervical cancer screening?

✍ Marc Arbyn; Guglielmo Ronco; Jack Cuzick; Nicolas Wentzensen; Philip E. Castle 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 113 KB

## Abstract Excellent recommendations exist for studying therapeutic and diagnostic questions. We observe that good guidelines on assessment of evidence for screening questions are currently lacking. Guidelines for diagnostic research (STARD), involving systematic application of the reference test

Hydrothermal salt—but how much?: Reply t

Hydrothermal salt—but how much?: Reply to Christopher Talbot on his comments to our articles

✍ Martin Hovland; Haakon Rueslaatten; Hans Konrad Johnsen 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 106 KB